Phase I dose escalation study of the safety, tolerability, pharmacokinetics and antiviral activity of Omega DUROS [an implantable drug delivery system containing omega interferon] and ribavirin in subjects with chronic hepatitis C previously treated with pegylated interferon and ribavirin

Trial Profile

Phase I dose escalation study of the safety, tolerability, pharmacokinetics and antiviral activity of Omega DUROS [an implantable drug delivery system containing omega interferon] and ribavirin in subjects with chronic hepatitis C previously treated with pegylated interferon and ribavirin

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Interferon omega; Ribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top